700 Shares in Azenta, Inc. (NASDAQ:AZTA) Purchased by AdvisorNet Financial Inc

AdvisorNet Financial Inc purchased a new position in shares of Azenta, Inc. (NASDAQ:AZTAGet Rating) during the second quarter, Holdings Channel reports. The firm purchased 700 shares of the company’s stock, valued at approximately $50,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Moody National Bank Trust Division purchased a new position in Azenta during the second quarter worth about $753,000. Vigilant Capital Management LLC purchased a new position in Azenta during the second quarter worth about $25,000. Amalgamated Bank purchased a new position in Azenta during the first quarter worth about $4,552,000. Adalta Capital Management LLC purchased a new position in Azenta during the first quarter worth about $414,000. Finally, IMA Wealth Inc. purchased a new position in Azenta during the first quarter worth about $1,818,000. 97.43% of the stock is currently owned by institutional investors and hedge funds.

Azenta Stock Performance

Azenta stock opened at $45.92 on Friday. Azenta, Inc. has a 1 year low of $45.51 and a 1 year high of $124.79. The company’s 50 day simple moving average is $59.02 and its 200-day simple moving average is $70.36. The company has a market capitalization of $3.44 billion, a price-to-earnings ratio of 1.59 and a beta of 1.54.

Azenta (NASDAQ:AZTAGet Rating) last announced its earnings results on Tuesday, August 9th. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.04. Azenta had a net margin of 391.34% and a return on equity of 1.47%. The firm had revenue of $132.74 million for the quarter, compared to the consensus estimate of $132.70 million. During the same period in the prior year, the firm earned $0.72 EPS. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis. Equities analysts expect that Azenta, Inc. will post 0.41 earnings per share for the current year.

Insider Buying and Selling

In other Azenta news, CFO Lindon G. Robertson bought 4,350 shares of the business’s stock in a transaction that occurred on Friday, August 19th. The shares were purchased at an average cost of $57.62 per share, with a total value of $250,647.00. Following the purchase, the chief financial officer now directly owns 100,571 shares in the company, valued at $5,794,901.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, COO Matthew Mcmanus purchased 8,625 shares of the stock in a transaction on Friday, August 19th. The stock was bought at an average price of $58.15 per share, for a total transaction of $501,543.75. Following the acquisition, the chief operating officer now directly owns 29,467 shares of the company’s stock, valued at approximately $1,713,506.05. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Lindon G. Robertson purchased 4,350 shares of the stock in a transaction on Friday, August 19th. The shares were purchased at an average price of $57.62 per share, with a total value of $250,647.00. Following the acquisition, the chief financial officer now directly owns 100,571 shares in the company, valued at $5,794,901.02. The disclosure for this purchase can be found here. 1.62% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. B. Riley reduced their target price on shares of Azenta from $94.00 to $82.00 in a research note on Thursday, July 14th. Needham & Company LLC reduced their price target on shares of Azenta from $94.00 to $74.00 and set a “buy” rating on the stock in a research note on Wednesday, August 10th. Evercore ISI reduced their price target on shares of Azenta to $68.00 in a research note on Monday, August 15th. Finally, TheStreet downgraded shares of Azenta from a “c-” rating to a “d+” rating in a research note on Thursday, September 1st.

About Azenta

(Get Rating)

Azenta, Inc provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.

Further Reading

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAGet Rating).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.